GB201913448D0 - Novel compounds and their use in therapy - Google Patents

Novel compounds and their use in therapy

Info

Publication number
GB201913448D0
GB201913448D0 GB201913448A GB201913448A GB201913448D0 GB 201913448 D0 GB201913448 D0 GB 201913448D0 GB 201913448 A GB201913448 A GB 201913448A GB 201913448 A GB201913448 A GB 201913448A GB 201913448 D0 GB201913448 D0 GB 201913448D0
Authority
GB
United Kingdom
Prior art keywords
therapy
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201913448A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
MMV Medicines for Malaria Venture
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MMV Medicines for Malaria Venture, Imperial College Innovations Ltd filed Critical MMV Medicines for Malaria Venture
Priority to GB201913448A priority Critical patent/GB201913448D0/en
Publication of GB201913448D0 publication Critical patent/GB201913448D0/en
Ceased legal-status Critical Current

Links

GB201913448A 2019-09-18 2019-09-18 Novel compounds and their use in therapy Ceased GB201913448D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201913448A GB201913448D0 (en) 2019-09-18 2019-09-18 Novel compounds and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201913448A GB201913448D0 (en) 2019-09-18 2019-09-18 Novel compounds and their use in therapy

Publications (1)

Publication Number Publication Date
GB201913448D0 true GB201913448D0 (en) 2019-10-30

Family

ID=68315304

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201913448A Ceased GB201913448D0 (en) 2019-09-18 2019-09-18 Novel compounds and their use in therapy

Country Status (1)

Country Link
GB (1) GB201913448D0 (en)

Similar Documents

Publication Publication Date Title
EP3250609A4 (en) Il13ra alpha 2 binding agents and use thereof in cancer treatment
IL284053A (en) Novel compounds and their use in therapy
GB201511382D0 (en) Novel compounds and their use in therapy
IL288728A (en) Anti-sortilin antibodies for use in therapy
GB201715194D0 (en) Compounds and their therapeutic use
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
IL286079A (en) Imidazolonylquinoline compounds and therapeutic uses thereof
EP4063489A4 (en) Composition and use thereof
IL284981A (en) Semaphorin-4d antagonists for use in cancer therapy
HUE058652T2 (en) Compounds and their use in the treatment of schistosomiasis
PT3325478T (en) New therapeutic compound and use in therapy
IL289371A (en) Methylthioninium for use in the treatment of synaptopathies
IL280555A (en) Substituted benzamides and their use in therapy
GB202014736D0 (en) Novel compounds and their use in therapy
GB201918541D0 (en) Therapeutic compounds and their use
GB2581035B (en) Novel compounds and their use in therapy
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
GB202104122D0 (en) Compounds and their use
EP3891123A4 (en) Oligo-benzamide analogs and their use in cancer treatment
GB201914640D0 (en) Novel compounds and their use in therapy
GB201913450D0 (en) Novel compounds and their use in therapy
GB201913448D0 (en) Novel compounds and their use in therapy
GB201909790D0 (en) Novel compounds and their use in therapy
GB201901272D0 (en) Novel compounds and their use in therapy
GB201906914D0 (en) Substituted naphtahlene diimdes and their use

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: IMPERIAL COLLEGE INNOVATIONS LIMITED

Free format text: FORMER OWNERS: IMPERIAL COLLEGE INNOVATIONS LIMITED;MEDICINES FOR MALARIA VENTURE (MMV)

AT Applications terminated before publication under section 16(1)